{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:00:57Z","timestamp":1775181657567,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.carrev.2018.01.003","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T03:05:39Z","timestamp":1515121539000},"page":"671-678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Long term outcomes of new generation drug eluting stents versus coronary artery bypass grafting for multivessel and\/or left main coronary artery disease. A Bayesian network meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"19","author":[{"given":"George S.","family":"Mina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussam","family":"Watti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demiana","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Shewale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratap","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paari","family":"Dominic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2018.01.003_bb0005","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/eurheartj\/ehr213","article-title":"Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and\/or three-vessel disease: 3-year follow-up of the SYNTAX trial","volume":"32","author":"Kappetein","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2018.01.003_bb0010","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2018.01.003_bb0015","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCULATIONAHA.107.739144","article-title":"Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the stent or surgery trial (SoS)","volume":"118","author":"Booth","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2018.01.003_bb0020","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0140-6736(02)11078-6","article-title":"Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the stent or surgery trial): a randomised controlled trial","volume":"360","author":"SoS Investigators","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2018.01.003_bb0025","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamainternmed.2013.12844","article-title":"Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease","volume":"174","author":"Sipahi","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.carrev.2018.01.003_bb0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jtcvs.2011.10.015","article-title":"2011 ACCF\/AHA guideline for coronary artery bypass graft surgery: executive summary","volume":"143","author":"Hillis","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carrev.2018.01.003_bb0035","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS Guidelines on myocardial revascularization","volume":"35","author":"Authors\/Task Force members","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2018.01.003_bb0040","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.110.003210","article-title":"Stent Thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug CoatingsClinical Perspective","volume":"123","author":"Kolandaivelu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2018.01.003_bb0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1615\/JLongTermEffMedImplants.v10.i12.120","article-title":"Influence of topography on endothelialization of stents: clues for new designs","volume":"10","author":"Simon","year":"2000","journal-title":"J Long-Term Eff Med Implants"},{"key":"10.1016\/j.carrev.2018.01.003_bb0050","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.113.001790","article-title":"Pathology of second-generation Everolimus-eluting stents versus first-generation Sirolimus- and paclitaxel-eluting stents in HumansCLINICAL PERSPECTIVE","volume":"129","author":"Otsuka","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2018.01.003_bb0055","doi-asserted-by":"crossref","first-page":"f6625","DOI":"10.1136\/bmj.f6625","article-title":"Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis","volume":"347","author":"Bangalore","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.carrev.2018.01.003_bb0060","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/eurheartj\/ehr479","article-title":"Lower risk of stent thrombosis and restenosis with unrestricted use of \u201cnew-generation\u201d drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR)","volume":"33","author":"Sarno","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2018.01.003_bb0065","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jcin.2013.07.009","article-title":"5-year results of a randomized comparison of XIENCE V Everolimus-eluting and TAXUS paclitaxel-eluting stents","volume":"6","author":"Gada","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2018.01.003_bb0070","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","article-title":"Simultaneous comparison of multiple treatments: combining direct and indirect evidence","volume":"331","author":"Caldwell","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.carrev.2018.01.003_bb0075","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/10618600.1998.10474787","article-title":"General methods for monitoring convergence of iterative simulations","volume":"7","author":"Brooks","year":"1998","journal-title":"J Comput Graph Stat"},{"key":"10.1016\/j.carrev.2018.01.003_bb0080","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/2046-4053-3-110","article-title":"A Microsoft-Excel-based tool for running and critically appraising network meta-analyses\u2014an overview and application of NetMetaXL","volume":"3","author":"Brown","year":"2014","journal-title":"Syst Rev"},{"key":"10.1016\/j.carrev.2018.01.003_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a1331","article-title":"Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis","volume":"337","author":"Stettler","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.carrev.2018.01.003_bb0090","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/0272989X12455847","article-title":"Evidence synthesis for decision making 4","volume":"33","author":"Dias","year":"2013","journal-title":"Med Decis Mak"},{"key":"10.1016\/j.carrev.2018.01.003_bb0095","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJMoa1415447","article-title":"Trial of Everolimus-eluting stents or bypass surgery for coronary disease","volume":"372","author":"Park","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2018.01.003_bb0100","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1056\/NEJMoa1610227","article-title":"Everolimus-eluting stents or bypass surgery for left main coronary artery disease","volume":"375","author":"Stone","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2018.01.003_bb0105","first-page":"1","article-title":"Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial","volume":"6736","author":"M\u00e4kikallio","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2018.01.003_bb0110","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/j.jacc.2015.03.033","article-title":"Randomized trial of stents versus bypass surgery for left main coronary artery disease: 5-year outcomes of the PRECOMBAT study","volume":"65","author":"Ahn","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2018.01.003_bb0115","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","article-title":"Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial","volume":"381","author":"Mohr","year":"2013","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.carrev.2018.01.003_bb0120","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.106.625475","article-title":"Five-year follow-up of the medicine, angioplasty, or surgery study (MASS II)","volume":"115","author":"Hueb","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2018.01.003_bb0125","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jacc.2004.12.081","article-title":"Five-year follow-up of the argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II)","volume":"46","author":"Rodriguez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2018.01.003_bb0130","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1161\/01.CIR.0000118504.61212.4B","article-title":"Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease","volume":"109","author":"Legrand","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2018.01.003_bb0135","doi-asserted-by":"crossref","first-page":"789","DOI":"10.4244\/EIJV7I7A125","article-title":"The three year follow-up of the randomised \u201call-comers\u201d trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS)","volume":"7","author":"Wykrzykowska","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2018.01.003_bb0140","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jcin.2015.03.028","article-title":"Final 5-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice the COMPARE trial (a trial of everolimus-eluting stents and paclitaxel stents for coronary revascularizat)","volume":"8","author":"Smits","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2018.01.003_bb0145","first-page":"519","article-title":"Why is the mammary artery so special and what protects it from atherosclerosis?","volume":"2","author":"Otsuka","year":"2013","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/j.carrev.2018.01.003_bb0150","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0975-3583(10)12003-8","article-title":"Percutaneous coronary intervention vs coronary artery bypass grafting in the management of chronic stable angina: a critical appraisal","volume":"1","author":"Singh","year":"2010","journal-title":"J Cardiovasc Dis Res"},{"key":"10.1016\/j.carrev.2018.01.003_bb0155","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/CIRCINTERVENTIONS.114.001346","article-title":"Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap?","volume":"7","author":"Bangalore","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2018.01.003_bb0160","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJMoa1412168","article-title":"Everolimus-eluting stents or bypass surgery for multivessel coronary disease","volume":"372","author":"Bangalore","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2018.01.003_bb0165","doi-asserted-by":"crossref","first-page":"g3859","DOI":"10.1136\/bmj.g3859","article-title":"Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis","volume":"348","author":"Windecker","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.carrev.2018.01.003_bb0170","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(17)32249-3","article-title":"Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial","volume":"390","author":"Kandzari","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2018.01.003_bb0175","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.002626","article-title":"Everolimus eluting stents versus coronary artery bypass graft surgery for patients with diabetes mellitus and multivessel disease","volume":"8","author":"Bangalore","year":"2015","journal-title":"Circ Cardiovasc Interv"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838918300034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838918300034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:13:51Z","timestamp":1761560031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838918300034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1553838918300034"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2018.01.003","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long term outcomes of new generation drug eluting stents versus coronary artery bypass grafting for multivessel and\/or left main coronary artery disease. A Bayesian network meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2018.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}